NanoString Technologies

Employees:
410
Market Cap:
$401.68 million
Revenue:
$86.25 million
5 Year Trend:
37.1%
Net Income:
$-48.49 million
NASDAQ:
NSTG

NanoString Technologies, Inc. (NASDAQ: NSTG) is a publicly held biotech company that specializes in development of cancer diagnostics tools. The companys technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications. Wikipedia

NanoString Technologies
Employees:
410
Market Cap:
$401.68 million
Revenue:
$86.25 million
5 Year Trend:
37.1%
Net Income:
$-48.49 million
NASDAQ:
NSTG

NanoString Technologies, Inc. (NASDAQ: NSTG) is a publicly held biotech company that specializes in development of cancer diagnostics tools. The companys technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications. Wikipedia

Feb 16, 3:46 AM

The #NSTGLOUNGE is open and ready for more people! Join the party on the 33rd floor #AGBT17

Feb 15, 5:30 PM

We have a full house here at our #AGBT17 luncheon workshop as Joseph Beechem PhD presents on our new Hyb & Seq technology!

Feb 14, 3:39 PM

Fast track to checkpoint inhibition with our technology! Come grab a T shirt and chat with an expert in Suite 220. #AGBT17

Dec 7, 10:48 PM

Congratulations from everyone here at NanoString, to Dr. Charles Perou on receiving the Susan G. Komen Brinker award for scientific distinction in basic research at #SABCS16 ! And thank you for continued work with us!

2

NanoString Technologies jobs